Medical Information Only: This medication is not sold on this site. The information provided is for reference purposes only. Please consult your local physician or pharmacist for treatment.
Uptravi Side Effects Center
Medically reviewed by Min Clinic Staff | Updated: January 2026
- Generic Name: uptravi selexipag tablets
- Brand Name: Uptravi
- Drug Class: PAH, Prostacyclin Agonists
Uptravi (Uptravi Selexipag Tablets) side effects drug center
Uptravi Side Effects Center
What Is Uptravi?
Uptravi (selexipag) is a prostacyclin receptor agonist indicated for the treatment of pulmonary arterial hypertension (PAH, WHO Group I) to delay disease progression and reduce the risk of hospitalization for PAH.
What Are Side Effects of Uptravi?
Common side effects of Uptravi include:
